Does growth hormone cause cancer?

Clinical Endocrinology

Volumn 64, Issue 2, 2006, Pages 115-121

  Jenkins, P J ^a   Mukherjee, A ^b   Shalet, S M ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; BINDING AFFINITY; CANCER; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL DAMAGE; CHILDHOOD CANCER; COLORECTAL CANCER; COMPARATIVE STUDY; FOLLOW UP; GENETICS; HEALTH SURVEY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS; MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; TUMOR RECURRENCE;

ACROMEGALY; ADULT; ANIMALS; CHILD; CHILD DEVELOPMENT; COLORECTAL NEOPLASMS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; RISK FACTORS;

EID: 33645022208     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02404.x     Document Type: Review

References (54)

1. Le Roith D. Bondy C. Yakar S. Liu J.L. Butler A. 2001 The somatomedin hypothesis: 2001 Endocrine Reviews 22 53 74
2. Laban C. Bustin S.A. Jenkins P.J. 2002 The GH-IGF-I axis and breast cancer Trends in Endocrinology and Metabolism 14 28 34
3. Bustin S.A. Jenkins P.J. 2001 The growth hormone-insulin-like growth factor-I axis and colorectal cancer Trends in Molecular Medicine 7 447 454
4. Pollak M.N. Schernhammer E.S. Hankinson S.E. 2004 Insulin-like growth factors and neoplasia Nature Reviews Cancer 4 505 518
5. Tornell J. Carlsson B. Pohjanen P. Wennbo H. Rymo L. Isaksson O. 1992 High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice Journal of Steroid Biochemistry and Molecular Biology 43 237 242
6. Bates P. Fisher R. Ward A. Richardson L. Hill D.J. Graham C.F. 1995 Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) British Journal of Cancer 72 1189 1193
7. Yang X.F. Beamer W.G. Huynh H. Pollak M. 1996 Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation Cancer Research 56 1509 1511
8. Arteaga C.L. Kitten L.J. Coronado E.B. Jacobs S. Kull F.C. Jr. Allred D.C. Osborne C.K. 1989 Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice Journal of Clinical Investigation 84 1418 1423
9. Pollak M. Blouin M.J. Zhang J.C. Kopchick J.J. 2001 Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist British Journal of Cancer 85 428 430
10. Wu Y. Yakar S. Zhao L. Hennighausen L. LeRoith D. 2002 Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis Cancer Research 62 1030 1035
11. Wu Y. Cui K. Miyoshi K. Hennighausen L. Green J.E. Setser J. LeRoith D. Yakar S. 2003 Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors Cancer Research 63 4384 4388
12. Bustin S.A. Dorudi S. Phillips S.M. Feakins R.M. Jenkins P.J. 2002 Local expression of insulin-like growth factor-I affects angiogenesis in colorectal cancer Tumour Biology 23 130 138
13. Sachdev D. Hartell J.S. Lee A.V. Zhang X. Yee D. 2004 A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells Journal of Biological Chemistry 279 5017 5024
14. Gunnell D.J. Smith G.D. Frankel S.J. Kemp M. Peters T.J. 1998 Socio-economic and dietary influences on leg length and trunk length in childhood: a reanalysis of the Carnegie (Boyd Orr) survey of diet and health in prewar Britain (1937-39) Paediatrics and Perinatal Epidemiology 12 96 113
15. De Stavola B.L. dos SantosSilvaI McCormack V. Hardy R.J. Kuh D.J. Wadsworth M.E. 2004 Childhood growth and breast cancer American Journal of Epidemiology 159 671 682
16. Stevenaert A. Beckers A. 1996 Presurgical Octreotide: treatment in acromegaly Metabolism 45 72 74
17. Ahlgren M. Melbye M. Wohlfahrt J. Sorensen T.I. 2004 Growth patterns and the risk of breast cancer in women New England Journal of Medicine 351 1619 1626
18. Gunnell D. Okasha M. Smith G.D. Oliver S.E. Sandhu J. Holly J.M. 2001 Height, leg length, and cancer risk: a systematic review Epidemiology Reviews 23 313 342
19. Shalet S.M. Clayton P.E. Price D.A. 1988 Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia Hormone Research 30 53 61
20. Taback S.P. Dean H.J. 1996 Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee Journal of Clinical Endocrinology and Metabolism 81 1693 1696
21. Swerdlow A.J. Reddingius R.E. Higgins C.D. Spoudeas H.A. Phipps K. Qiao Z. Ryder W.D. Brada M. Hayward R.D. Brook C.G. Hindmarsh P.C. Shalet S.M. 2000 Growth hormone treatment of children with brain tumors and risk of tumor recurrence Journal of Clinical Endocrinology and Metabolism 85 4444 4449
22. Sklar C.A. Mertens A.C. Mitby P. Occhiogrosso G. Qin J. Heller G. Yasui Y. Robison L.L. 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study Journal of Clinical Endocrinology and Metabolism 87 3136 3141
23. Neglia J.P. Friedman D.L. Yasui Y. Mertens A.C. Hammond S. Stovall M. Donaldson S.S. Meadows A.T. Robison L.L. 2001 Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study Journal of National Cancer Institute 93 618 629
24. Wada E. Murata M. Watanabe S. 1989 Acute lymphoblastic leukemia following treatment with human growth hormone in a boy with possible preanemic Fanconi's anemia Japanese Journal of Clinical Oncology 19 36 39
25. Gotherstrom G. Svensson J. Koranyi J. Alpsten M. Bosaeus I. Bengtsson B. Johannsson G. 2001 A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices Journal of Clinical Endocrinology and Metabolism 86 4657 4665
26. Attanasio A.F. Bates P.C. Ho K.K. Webb S.M. Ross R.J. Strasburger C.J. Bouillon R. Crowe B. Selander K. Valle D. Lamberts S.W. 2002 Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status - 3-year results from the HypoCCS database Journal of Clinical Endocrinology and Metabolism 87 1600 1606
27. Monson J.P. 2003 Long-term experience with GH replacement therapy: efficacy and safety European Journal of Endocrinology 148 Suppl 2 S9 14
28. Swerdlow A.J. Higgins C.D. Adlard P. Preece M.A. 2002 Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study Lancet 360 273 277
29. Sperling M.A. Saenger P.H. Ray H. Tom W. Rose S.R. 2002 Growth hormone treatment and neoplasia: coincidence or consequence? Journal of Clinical Endocrinology and Metabolism 87 5351 5352
30. Emerman J.T. Leahy M. Gout P.W. Bruchovsky N. 1985 Elevated growth hormone levels in sera from breast cancer patients Hormone and Metabolic Research 17 421 424
31. Peyrat J.P. Bonneterre J. Hecquet B. Vennin P. Louchez M.M. Fournier C. Lefebvre J. Demaille A. 1993 Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer European Journal of Cancer 29A 492 497
32. Giovannucci E. Pollak M.N. Platz E.A. Willett W.C. Stampfer M.J. Majeed N. Colditz G.A. Speizer F.E. Hankinson S.E. 2000 A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women Cancer Epidemiology, Biomarkers & Prevention 9 345 349
33. Hankinson S.E. Willett W.C. Colditz G.A. Hunter D.J. Michaud D.S. Deroo B. Rosner B. Speizer F.E. Pollak M. 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer Lancet 351 1393 1396
34. Ma J. Pollak M. Giovannucci E. Chan J.M. Tao Y. Hennekens C.H. 1999 S tampfer and prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3 Journal of the National Cancer Institute 91 620 625
35. Manousos O. Souglakos J. Bosetti C. Tzonou A. Chatzidakis V. Trichopoulos D. Adami H.O. Mantzoros C. 1999 IGF-I and IGF-II in relation to colorectal cancer International Journal of Cancer 83 15 17
36. Burroughs K.D. Dunn S.E. Barrett J.C. Taylor J.A. 1999 Insulin-like growth factor-I: a key regulator of human cancer risk? Journal of National Cancer Institute 91 579 581
37. el Atiq F. Garrouste F. Remacle-Bonnet M. Sastre B. Pommier G. 1994 Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer International Journal of Cancer 57 491 497
38. Renehan A.G. Zwahlen M. Minder C. O'Dwyer S.T. Shalet S.M. Egger M. 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 1346 1353
39. Baxter R.C. Butt A.J. Schedlich L.J. Martin J.L. 2000 Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3 Growth Hormone and IGF Research 10 S10 S11
40. Gill Z.P. Perks C.M. Newcomb P.V. Holly J.M. 1997 Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner Journal of Biological Chemistry 272 25602 25607
41. Jenkins P.J. Besser M. 2001 Clinical perspective: acromegaly and cancer: a problem Journal of Clinical Endocrinology and Metabolism 86 2935 2941
42. Renehan A.G. O'Connell J. O'Halloran D. Shanahan F. Potten C.S. O'Dwyer S.T. Shalet S.M. 2003 Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications Hormone and Metabolic Research 35 712 725
43. Melmed S. 2001 Acromegaly and cancer: not a problem? Journal of Clinical Endocrinology and Metabolism 86 2929 2934
44. Jenkins P.J. Fairclough P.D. Richards T. Lowe D.G. Monson J. Grossman A. Wass J.A.H. Besser G.M. 1997 Acromegaly, colonic polyps and carcinoma Clinical Endocrinology 47 17 22
45. Renehan A.G. Bhaskar P. Painter J.E. O'Dwyer S.T. Haboubi N. Ball S.G. Shalet S.M. 2000 The prevalence and characteristics of colorectal neoplasia in acromegaly Journal of Clinical Endocrinology and Metabolism 85 3417 3424
46. Jenkins P.J. Frajese V. Jones A.-M. Camacho-Hubner C. Lowe D.G. Fairclough P.D. Chew S.L. Grossmann A.B. Monson J. Besser G.M. 2000 IGF-I and the development of colorectal neoplasia in acromegaly Journal of Clinical Endocrinology and Metabolism 85 3218 3221
47. Cats A. Dullaart R.P. Kleibeuker J.H. Kuipers F. Sluiter W.J. Hardonk M.J. de Vries E.G. 1996 Increased epithelial cell proliferation in the colon of patients with acromegaly Cancer Research 56 523 526
48. Orme S.M. McNally R.J. Cartwright R.A. Belchetz P.E. 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study Journal of Clinical Endocrinology and Metabolism 83 2730 2734
49. Nabarro J.D. 1987 Acromegaly Clinical Endocrinology 26 481 512
50. Dunn S.E. Ehrlich M. Sharp N.J. Reiss K. Solomon G. Hawkins R. Baserga, R. & Barrett J.C. 1998 A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer Cancer Research 58 3353 3361
51. Adachi Y. Lee C.T. Coffee K. Yamagata N. Ohm J.E. Park K.H. Dikov M.M. Nadaf S.R. Arteaga C.L. Carbone D.P. 2002 Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines Gastroenterology 123 1191 1204
52. Wen B. Deutsch E. Marangoni E. Frascona V. Maggiorella L. Abdulkarim B. Chavaudra N. Bourhis J. 2001 Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells British Journal of Cancer 85 2017 2021
53. Friend K.E. 2001 Cancer and the potential place for growth hormone receptor antagonist therapy Growth Hormone and IGF Research 11 S121 S123
54. Maple S. Fernandes J. Khandwala H. Scarlett J.A. Davis R.A. Flyvbjerg A. et al. 2001 Pegvisomant inhibits tumor growth in a syngenic model of colon cancer metastasis Proceedings of the 83rd American Endocrine Society 218